• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Quanterix Corporation - Common Stock (NQ:QTRX)

    2.420 -1.610 (-39.95%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,001,933
    Open 2.300
    Bid (Size) 2.410 (100)
    Ask (Size) 2.450 (7,000)
    Prev. Close 4.030
    Today's Range 2.150 - 2.600
    52wk Range 2.395 - 8.770
    Shares Outstanding 38,063,618
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Here are the top movers in Monday's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Monday's session. ↗
    Via Chartmill

    Performance

    YTD
    -62.4%
    -62.4%
    1 Month
    -37.6%
    -37.6%
    3 Month
    -13.6%
    -13.6%
    6 Month
    -60.8%
    -60.8%
    1 Year
    -47.2%
    -47.2%

    More News

    Read More
    News headline image
    Quanterix Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    Quanterix (NASDAQ:QTRX) Beats Q1 2026 EPS Estimates Despite Revenue Miss ↗
    Via Chartmill
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Quanterix Names Jim Gute Chief Commercial Officer
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Releases Financial Results for the Second Quarter of 2026
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
    From Quanterix
    Via Business Wire
    News headline image
    Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Announces Planned Transition of Chief Financial Officer
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix (QTRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Quanterix Releases Financial Results for the First Quarter of 2026
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows
    From Quanterix
    Via Business Wire
    News headline image
    Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
    From Quanterix Corporation
    Via Business Wire
    News headline image
    AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Debuts Content Innovation Engine at AACR 2026
    From Quanterix Corporation
    Via Business Wire
    News headline image
    Quanterix Corporation Announces Date of 2026 Annual Meeting
    From Quanterix Corporation
    Via Business Wire

    Frequently Asked Questions

    Is Quanterix Corporation - Common Stock publicly traded?
    Yes, Quanterix Corporation - Common Stock is publicly traded.
    What exchange does Quanterix Corporation - Common Stock trade on?
    Quanterix Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Quanterix Corporation - Common Stock?
    The ticker symbol for Quanterix Corporation - Common Stock is QTRX on the Nasdaq Stock Market
    What is the current price of Quanterix Corporation - Common Stock?
    The current price of Quanterix Corporation - Common Stock is 2.420
    When was Quanterix Corporation - Common Stock last traded?
    The last trade of Quanterix Corporation - Common Stock was at 08/10/26 04:00 PM ET
    What is the market capitalization of Quanterix Corporation - Common Stock?
    The market capitalization of Quanterix Corporation - Common Stock is 92.11M
    How many shares of Quanterix Corporation - Common Stock are outstanding?
    Quanterix Corporation - Common Stock has 92M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.